Center for Advanced Practice
Title
Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum.
Publication Title
Journal of thrombosis and thrombolysis
Document Type
Article
PubMed ID
35579732
Abstract
Thromboembolism is a common and deadly consequence of COVID-19 infection for hospitalized patients. Based on clinical evidence pre-dating the COVID-19 pandemic and early observational reports, expert consensus and guidance documents have strongly encouraged the use of prophylactic anticoagulation for patients hospitalized for COVID-19 infection. More recently, multiple clinical trials and larger observational studies have provided evidence for tailoring the approach to thromboprophylaxis for patients with COVID-19. This document provides updated guidance for the use of anticoagulant therapies in patients with COVID-19 from the Anticoagulation Forum, the leading North American organization of anticoagulation providers. We discuss ambulatory, in-hospital, and post-hospital thromboprophylaxis strategies as well as provide guidance for patients with thrombotic conditions who are considering COVID-19 vaccination.
Keywords
Anticoagulants, COVID-19, COVID-19 Vaccines, Humans, Pandemics, Venous Thromboembolism
DOI
10.1007/s11239-022-02643-3
Publication Date
8-1-2022
Citation
Barnes, G., Burnett, A., Allen, A., Ansell, J., Blumenstein, M., Clark, N., Crowther, M., Dager, W., Deitelzweig, S., Ellsworth, S., Garcia, D., Kaatz, S., Raffini, L., Rajasekhar, A., Beek, A., & Minichiello, T. (2022). Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum.. Journal of thrombosis and thrombolysis, 54 (2), 197-210. https://doi.org/10.1007/s11239-022-02643-3
